Logos Global Management’s Tyra Biosciences TYRA Stock Holding History

Logos Global Management’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.6M	Buy	850,000 +640,000	+305%	+$20.7M	1.63%	21
2025 Q4	$5.52M	Buy	+210,000	New	+$3.86M	0.33%	51
2023 Q4	–	Sell	-31,872	Closed	-$439K	–	70
2023 Q3	$439K	Hold	31,872	–	–	0.06%	54
2023 Q2	$543K	Sell	31,872 -55,801	-64%	-$809K	0.07%	50
2023 Q1	$1.41M	Sell	87,673 -23,183	-21%	-$276K	0.2%	39
2022 Q4	$843K	Sell	110,856 -16,460	-13%	-$116K	0.1%	38
2022 Q3	$1.12M	Sell	127,316 -39,210	-24%	-$359K	0.14%	35
2022 Q2	$1.19M	Sell	166,526 -86,200	-34%	-$686K	0.22%	26
2022 Q1	$2.7M	Sell	252,726 -220,668	-47%	-$2.62M	0.35%	30
2021 Q4	$6.66M	Sell	473,394 -530,000	-53%	-$10.5M	0.69%	33
2021 Q3	$17.6M	Buy	+1,003,394	New	+$19.2M	1.27%	25

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

APMC

Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Logos Global Management's TYRA Position: Q1 2026 in Review

Logos Global Management increased its Tyra Biosciences (TYRA) stake by 305% in Q1 2026, buying an estimated $20.7M and bringing the position to 850,000 shares worth $32.6M. The position accounts for 1.63% of the portfolio, ranked #21.

Logos Global Management first reported a position in TYRA in Q3 2021 and has held it in 11 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

Logos Global Management held 850,000 shares of Tyra Biosciences worth $32.6M as of Q1 2026.
Logos Global Management bought 640,000 Tyra Biosciences shares in Q1 2026, an estimated $20.7M.
Tyra Biosciences made up 1.63% of Logos Global Management's portfolio in Q1 2026, its #21 holding.
Logos Global Management first reported a position in Tyra Biosciences in Q3 2021 and has held it in 11 quarters since.
164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Logos Global Management's 13F filing for Q1 2026, filed 15 May 2026.